Robot heart scan could bring specialist care to remote islands
NCT ID NCT07265986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a robot-assisted remote ultrasound can measure heart function as accurately as a standard in-person ultrasound. About 50 adults with or at risk for heart failure will get both types of scans. The goal is to see if remote scans can help patients on smaller islands get better heart care without traveling.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * Free, informed and written consent signed by the participant and the investigator * Person affiliated or benefiting from a social security scheme. * Patient meeting at least one of the following criteria: * Systematic cardiovascular check-up or asymptomatic patient with cardiovascular risk factor (hypertension, diabetes, obesity, tobacco, alcohol) * Clinical suspicion of heart disease and/or chronic heart failure with stability of at least one week. * Family history of heart disease and/or sudden death Exclusion Criteria: * Patient requiring urgent cardiological management with transfer to the University Hospital * Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week) * Pregnant women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Echocardiography, doppler are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cabinet de cardiologie TONCOEURTONKA
NOT_YET_RECRUITINGPetit-Canal, 97131, Guadeloupe
-
Centre Hospitalier Sainte-Marie de Marie-Galante
RECRUITINGGrand-Bourg, 97122, Guadeloupe
-
Centre de Cardiologie Zac Colin
NOT_YET_RECRUITINGPetit-Bourg, 97170, Guadeloupe
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?